Orthopedic Biomaterials Market Analysis, Size, Trends | China | MedSuite

Orthopedic Biomaterials Market Analysis, Size, Trends | China | MedSuite

0

Bone graft substitutes are designed to fill bone voids, which eliminates the need for autograft harvesting of the patient’s own bone. Viscosupplementation products are injected directly into the affected knee joint to relieve pain caused by osteoarthritis. Growth factors are naturally occurring molecules in the body that mediate various cellular functions.

  • Year: 2020
  • Scope: 2016-2026
  • Region: China
  • Published Date: 02/04/2020
  • Pages: 268
  • Type: MedSuite

Surgical procedures that require the use of orthopedic biomaterials are generally associated with diseases and indications that become more prevalent in the population with an increase in age, such as osteoarthritis of the spine and knee. In 2019, approximately 12% of the Chinese population was aged 65 and over; this proportion is projected to grow steadily over the forecast period, as further cohorts of baby boomers turn 65. Growth of this population is expected to stimulate growth in all segments of the orthopedic biomaterials market.

While this report suite contains all data, each of the markets are also available as stand alone MedCore reports. This allows you to get access to only the market research that you need. You can view all these included reports and segmentation here:

  • Procedure Numbers for Orthobiologics – MedPro: Using a number of databases, internal and external, we’re able to provide you with the total volume of orthopedic biomaterials procedures being performed for each of the markets mentioned in this suite of reports.
  • Orthopedic Bone Graft Substitute Makrket – MedCore: Bone is a biologically active tissue and will regenerate whenever possible; however, there are instances where the damage is significant enough to warrant a scaffold to help rejoin the fissure or cavity. Bone grafting is a surgical procedure in which damaged bone is replaced with autograft tissue, allograft tissue or a bone graft substitute, which can be either synthetic or metal.
  • Hyaluronic Acid Viscosupplementation Market – MedCore: Hyaluronic acids (HAs) are naturally occurring biopolymer fluids found in the joints that help cushion them from wear. Sufferers of osteoarthritis are deficient in these fluids. One of the treatment options for these patients is HA viscosupplement injections. Viscosupplements are injectable products that come in three varieties of injection regimens. The market consisted of single-injection, three-injection and five-injection. These products are classified as medical devices in the majority of circumstances. In China, however, HA products are classified as drugs.
  • Orthopedic Growth Factor Market – MedCore: Growth factors are a group of small, soluble proteins that bind onto cell surface receptors, triggering a series of signals that regulate the body’s ability to grow, renew and heal. Due to the regenerative properties of growth factors, they have been exploited for bone healing in orthopedic applications.

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Forecasts Until 2026, and Historical Data to 2016
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Procedure Volumes
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios for Top Competitors
  • Related Press Releases from Top Competitors

Orthobiologics Market Share Insights

In 2019, the leading competitor in the Chinese orthopedic biomaterials market was Kunming Baker Norton, which was attributed to its leading position in the HA viscosupplementation market. Kunming Baker Norton’s portfolio includes the five-injection ARTZ® product line, which is originally manufactured by Seikagaku.

TABLE OF CONTENTS ILIST OF FIGURES VIIILIST OF CHARTS XV

EXECUTIVE SUMMARY 1

CHINESE ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 1COMPETITIVE ANALYSIS 3MARKET TRENDS 5MARKET DEVELOPMENTS 6PROCEDURE NUMBERS 7MARKETS INCLUDED 8KEY REPORT UPDATES 10VERSION HISTORY 10

RESEARCH METHODOLOGY 11

Step 1: Project Initiation & Team Selection 11Step 2: Prepare Data Systems and Perform Secondary Research 14Step 3: Preparation for Interviews & Questionnaire Design 16Step 4: Performing Primary Research 17Step 5: Research Analysis: Establishing Baseline Estimates 19Step 6: Market Forecast and Analysis 20Step 7: Identify Strategic Opportunities 22Step 8: Final Review and Market Release 23Step 9: Customer Feedback and Market Monitoring 24

PRODUCT ASSESSMENT 25

2.1 INTRODUCTION 252.2 PRODUCT PORTFOLIOS 252.2.1 Bone Graft Substitutes 262.2.2 Growth Factors 322.2.2.1 Other Products 352.2.3 Hyaluronic Acid Viscosupplementation (HAV) 372.3 REGULATORY ISSUES AND RECALLS 402.3.1 Bone Graft Substitutes 402.3.1.1 Allografts 402.3.1.1.1 MTF 402.3.1.2 DBM 402.3.1.2.1 AlloSource 402.3.1.2.2 SeaSpine 412.3.1.2.3 RTI Surgical 412.3.1.3 Synthetics 412.3.1.3.1 Abyrx 412.3.1.3.2 Zimmer Biomet 422.3.2 Growth Factors 422.3.2.1.1 Medtronic 422.3.3 Hyaluronic Acid Viscosupplementation 432.3.3.1 Three-injection 432.3.3.1.1 Ferring Pharmaceuticals 432.4 CLINICAL TRIALS 442.4.1 Bone Graft Substitutes 442.4.1.1 Allografts 442.4.1.1.1 Providence Medical Technology 442.4.1.1.2 The University of Texas Health Science 442.4.1.1.3 University of Winchester 452.4.1.2 BDM 452.4.1.2.1 K2M 452.4.1.2.2 Zimmer Biomet 462.4.1.3 Synthetics 462.4.1.3.1 Baxter 462.4.1.3.2 Bonesupport 472.4.1.3.3 DePuy Synthes 472.4.1.3.4 NuVasive 492.4.1.3.5 RTI surgical 492.4.1.3.6 Sunstar GUIDOR 502.4.1.4 Other materials and comparison 512.4.1.4.1 Seoul National University Hospital. 512.4.1.4.2 Sewon Cellontech 512.4.1.4.3 SurgaColl Technologies Limited 522.4.1.4.4 University of Colorado 522.4.1.4.5 University of Padova 532.4.2 Growth Factors 532.4.2.1.1 Bioventus 532.4.2.1.2 Cerapedics 542.4.2.1.3 CGBio 542.4.2.1.4 Isto 552.4.2.1.5 Medtronic 552.4.2.1.6 NuVasive 572.4.2.1.7 Wright 572.4.2.1.8 Others 582.4.3 Hyaluronic Acid Viscosupplementation 592.4.3.1.1 Anika Therapeutics 592.4.3.1.2 Bioventus 602.4.3.1.3 Cairo University 612.4.3.1.4 Ferring Pharmaceuticals 612.4.3.1.5 Federal University of Minas Gerais 622.4.3.1.6 Fidia Pharma USA Inc. 622.4.3.1.7 Istituto Ortopedico Rizzoli 632.4.3.1.8 University Hospital 632.4.3.1.9 Universidade Nova de Lisboa 64

CHINA ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 65

3.1 INTRODUCTION 653.1.1 Bone Graft Substitutes 653.1.2 Growth Factors 653.1.3 Hyaluronic Acid (HA) Viscosupplementation 663.2 CURRENCY EXCHANGE RATE 673.3 MARKET OVERVIEW AND TREND ANALYSIS 683.4 DRIVERS AND LIMITERS 763.4.1 Market Drivers 763.4.2 Market Limiters 763.5 COMPETITIVE MARKET SHARE ANALYSIS 783.6 MERGERS AND ACQUISITIONS 843.7 COMPANY PROFILES 863.7.1 Anika Therapeutics 863.7.2 Bioventus 873.7.3 DePuy Synthes 883.7.4 Ferring Pharmaceuticals 893.7.5 Fidia Pharmaceuticals 903.7.6 Genzyme (Sanofi Group) 913.7.7 Harvest Technologies (Terumo BCT) 923.7.8 Integra LifeSciences 933.7.9 Medtronic 943.7.10 Musculoskeletal Transplant Foundation (MTF) 963.7.11 NuVasive 973.7.12 Orthofix 983.7.13 RTI Surgical 993.7.14 Stryker 1003.7.15 Vericel Corporation (formerly Aastrom Bioscience) 1013.7.16 Zimmer Biomet 1023.8 SWOT ANALYSIS 1043.8.1 Anika Therapeutics 1043.8.2 Bioventus 1063.8.3 DePuy Synthes 1083.8.4 Ferring Pharmaceuticals 1093.8.5 Fidia Pharmaceuticals 1103.8.7 Harvest Technologies (Terumo BCT) 1123.8.8 Integra LifeSciences 1133.8.9 Medtronic 1143.8.10 Musculoskeletal Transplant Foundation (MTF) 1153.8.11 NuVasive 1163.8.12 Orthofix 1173.8.14 Stryker 1193.8.15 Vericel Corporation (formerly Aastrom Bioscience) 1203.8.16 Zimmer Biomet 121

PROCEDURE NUMBERS 123

4.1 INTRODUCTION 1234.2 PROCEDURES 1244.2.1 Orthopedic Biomaterial Procedures by Segment 1244.2.2 Orthopedic Bone Grafting Procedures 1264.2.2.1 Units per Procedure by Indication 1264.2.2.2 Orthopedic Bone Grafting Procedures by Material 1274.2.2.2.1 Autograft Procedures by Indication 1294.2.2.2.2 Allograft Procedures by Indication 1324.2.2.2.3 DBM Procedures by Indication 1354.2.2.2.4 Synthetic Procedures by Indication 1384.2.2.3 Orthopedic Bone Grafting Procedures by Indication 1414.2.3 Orthopedic Growth Factor Procedures 1444.2.4 Hyaluronic Acid Supplementation Procedures 1464.2.4.1 Hyaluronic Acid Supplementation Procedures by Injection Cycle 146ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET 1485.1 INTRODUCTION 1485.2 MARKET OVERVIEW 1495.2.1 Orthopedic Bone Graft Substitute Market by Material 1495.2.2 Orthopedic Bone Graft Substitute Market by Indication 1555.3 MARKET ANALYSIS AND FORECAST 1615.3.1 Total Orthopedic Bone Graft Substitute Market 1615.3.2 Orthopedic Bone Graft Substitute Market by Material 1635.3.2.1 Allograft Bone Graft Substitute Market 1635.3.2.1.1 Allograft Bone Graft Substitute Market by Indication 1655.3.2.2 Demineralized Bone Matrix Allograft Bone Graft Substitute Market 1795.3.2.2.1 Demineralized Bone Matrix Allograft Bone Graft Substitute Market by Indication 1815.3.2.3 Synthetic Bone Graft Substitute Market 1955.3.2.3.1 Synthetic Bone Graft Substitute Market by Indication 1975.3.3 Orthopedic Bone Graft Substitute Market by Indication 2115.3.3.1 Spine Bone Graft Substitute Market 2115.3.3.2 Cervical Spine Bone Graft Substitute Market 2135.3.3.3 Thoracolumbar Spine Bone Graft Substitute Market 2155.3.3.4 Trauma Bone Graft Substitute Market 2175.3.3.5 Non-Union Trauma Bone Graft Substitute Market 2195.3.3.6 Fresh Fracture Trauma Bone Graft Substitute Market 2215.3.3.7 Large Joint Reconstruction Bone Graft Substitute Market 2235.3.3.8 Hip Reconstruction Bone Graft Substitute Market 2255.3.3.9 Knee Reconstruction Bone Graft Substitute Market 2275.3.3.10 Foot Reconstruction Bone Graft Substitute Market 2295.3.3.11 Craniomaxillofacial Bone Graft Substitute Market 2315.3.3.12 Oncology Bone Graft Substitute Market 2335.4 DRIVERS AND LIMITERS 2355.4.1 Market Drivers 2355.4.2 Market Limiters 2355.5 COMPETITIVE MARKET SHARE ANALYSIS 237

ORTHOPEDIC GROWTH FACTOR MARKET 241

6.1 INTRODUCTION 2416.2 MARKET ANALYSIS AND FORECAST 2426.3 DRIVERS AND LIMITERS 2446.3.1 Market Drivers 2446.3.2 Market Limiters 2446.4 COMPETITIVE MARKET SHARE ANALYSIS 246

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 247

7.1 INTRODUCTION 2477.1.1 Benefits of Viscosupplementation 2487.1.2 Synovial Fluid 2487.2 MARKET OVERVIEW 2497.3 MARKET ANALYSIS AND FORECAST 2557.3.1 Total Hyaluronic Acid Viscosupplementation Market 2557.3.2 Three-Injection Hyaluronic Acid Viscosupplementation Market 2577.3.3 Five-Injection Hyaluronic Acid Viscosupplementation Market 2597.4 DRIVERS AND LIMITERS 2617.4.1 Market Drivers 2617.4.2 Market Limiters 2617.5 COMPETITIVE MARKET SHARE ANALYSIS 263

ABBREVIATIONS 267

 

All Companies Analyzed in this Study

  • Allgens Medical
  • Anika Therapeutics
  • Biocomposites
  • Bio-lu Biomaterials
  • Bloomage Biotechnology
  • DePuy Synthes
  • FocusChem Biotech
  • Guona Keji
  • Haohai Biological Technology
  • Harbin Gloria Pharmaceuticals
  • Jingjia Medical
  • Jinxingda Company
  • Kunming Baker Norton
  • Medtronic
  • Meiji Seika Pharma
  • NovaBone
  • Osteolink Biomaterials
  • Rebone Biomaterials
  • Sanofi
  • Seikagaku
  • Shanghai AnJiu Biotechnology
  • Shanghai Jingfeng Pharmaceutical
  • Shanxi OsteoRad Biomaterial
  • Stryker
  • Wright Medical
  • Xinkangchen
  • Yunkanghengye Company
  • Zimmer Biomet

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology


close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link
close-link